CG
CEMI

Cutler Group’s Chembio diagnostics, Inc. CEMI Stock Holding History

Cutler Group’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,700
Closed – – 4461
2023
Q1 		$0 Sell
1,700
-310
-15% -$121 ﹤0.01% 5134
2022
Q4 		$0 Sell
2,010
-152
-7% -$45 ﹤0.01% 5688
2022
Q3 		$0 Sell
2,162
-1,394
-39% -$951 ﹤0.01% 5875
2022
Q2 		$2K Buy
3,556
+38
+1% +$25 ﹤0.01% 4474
2022
Q1 		$2K Sell
3,518
-15,506
-82% -$14.5K ﹤0.01% 4863
2021
Q4 		$21K Sell
19,024
-25,894
-58% -$52.7K ﹤0.01% 3108
2021
Q3 		$112K Buy
44,918
+44,418
+8,884% +$123K 0.01% 1826
2021
Q2 		$1K Sell
500
-4,300
-90% -$15K ﹤0.01% 5560
2021
Q1 		$16K Sell
4,800
-2,499
-34% -$13.9K ﹤0.01% 3417
2020
Q4 		$34K Sell
7,299
-1,751
-19% -$9.04K ﹤0.01% 2293
2020
Q3 		$43K Sell
9,050
-3,074
-25% -$14.6K ﹤0.01% 1895
2020
Q2 		$39K Buy
+12,124
New +$115K ﹤0.01% 1927

Other funds holding CEMI

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Cutler Group's CEMI Position: Q2 2023 in Review

Cutler Group sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2023, closing a stake of 1,700 shares.

Cutler Group first reported a position in CEMI in Q2 2020 and held it in 12 quarters. The position peaked at $112K in Q3 2021. 1 fund tracked by Wall St. Rank holds CEMI as of Q2 2023.

  • Cutler Group reported no remaining Chembio diagnostics, Inc. position as of Q2 2023 after selling out during the quarter.
  • Cutler Group sold 1,700 Chembio diagnostics, Inc. shares in Q2 2023.
  • Cutler Group first reported a position in Chembio diagnostics, Inc. in Q2 2020 and held it in 12 quarters.
  • Cutler Group's Chembio diagnostics, Inc. position peaked at $112K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2023.

Based on Cutler Group's 13F filing for Q2 2023, filed 18 Jul 2023.